Biopharmaceutical company Senda Biosciences announced Wednesday that veteran biotech attorney Barbara Bispham has joined its leadership roster as general counsel.

Barbara Bispham, general counsel of Senda Biosciences. (Courtesy photo)

Bispham joins Senda from BridgeBio Pharma, where she was head of legal. At Senda, she replaces Lynette Herscha, who left in July to become chief operating officer at Immunitas Therapeutics.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]